OpenURL Connection Search

Select item for more details and to access through your institution.

Issue Information.
Published in:
Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 9, p. 499, doi. 10.1002/bdd.2038
Publication type:
Article
Acetylshikonin is a novel non-selective cytochrome P450 inhibitor.
Published in:
Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 9, p. 553, doi. 10.1002/bdd.2101
By:
- Shon, Jong Cheol;
- Phuc, Nguyen Minh;
- Kim, Won Cheol;
- Heo, Jae Kyung;
- Wu, Zhexue;
- Lee, Hyunyoung;
- Liu, Kwang‐Hyeon
Publication type:
Article
Impact of enzalutamide and its main metabolite N-desmethyl enzalutamide on pharmacokinetically important drug metabolizing enzymes and drug transporters.
Published in:
Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 9, p. 517, doi. 10.1002/bdd.2103
By:
- Weiss, Johanna;
- Kocher, Jutta;
- Mueller, Corina;
- Rosenzweig, Stephanie;
- Theile, Dirk
Publication type:
Article
5-Fluorouracil treatment alters the expression of intestinal transporters in rats.
Published in:
Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 9, p. 509, doi. 10.1002/bdd.2102
By:
- Yotsumoto, Keiichi;
- Akiyoshi, Takeshi;
- Wada, Naoki;
- Imaoka, Ayuko;
- Ohtani, Hisakazu
Publication type:
Article
Multiple organic cation transporters contribute to the renal transport of sulpiride.
Published in:
Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 9, p. 526, doi. 10.1002/bdd.2104
By:
- Li, Liping;
- Weng, Yayun;
- Wang, Wei;
- Bai, Mengru;
- Lei, Hongmei;
- Zhou, Hui;
- Jiang, Huidi
Publication type:
Article
Species-related exposure of phase II metabolite gemfibrozil 1-O-β-glucuronide between human and mice: A net induction of mouse P450 activity was revealed.
Published in:
Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 9, p. 535, doi. 10.1002/bdd.2105
By:
- Luo, Min;
- Dai, Manyun;
- Lin, Hante;
- Xie, Minzhu;
- Lin, Jiao;
- Liu, Aiming;
- Yang, Julin
Publication type:
Article
Effects of proton pump inhibitors and famotidine on elimination of plasma methotrexate: Evaluation of drug-drug interactions mediated by organic anion transporter 3.
Published in:
Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 9, p. 501, doi. 10.1002/bdd.2091
By:
- Narumi, Katsuya;
- Sato, Yu;
- Kobayashi, Masaki;
- Furugen, Ayako;
- Kasashi, Kumiko;
- Yamada, Takehiro;
- Teshima, Takanori;
- Iseki, Ken
Publication type:
Article
Influence of body composition on disposition of the highly fat distributed compound as analysed by physiologically based pharmacokinetic (PBPK) modeling and simulation.
Published in:
Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 9, p. 543, doi. 10.1002/bdd.2106
By:
- Goto, Akihiko;
- Tagawa, Yoshihiko;
- Moriya, Yuu;
- Sato, Sho;
- Yamamoto, Masami;
- Wakabayashi, Takeshi;
- Tsukamoto, Tetsuya;
- DeJongh, Joost;
- Steeg, Tamara J.;
- Moriwaki, Toshiya;
- Asahi, Satoru
Publication type:
Article

Found: 8